ArticleInternational journal of general medicine2025
IGF2BP1 Enhances Neprilysin mRNA Stability to Promote Proliferation, Invasion, and Angiogenesis in Placental Trophoblasts.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Linking Oxidative Stress to Placental Dysfunction: The Key Role of Mitochondria in Trophoblast Function.Medical sciences (Basel, Switzerland) · 2026Review
- Trophoblast Function in Preeclampsia: Decoding the Mechanistic Roles of Coding and Non-Coding Genes.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Preeclampsia (PE) is a severe gestational disorder characterized by sudden hypertension and proteinuria, with substantial risks to both mother and fetus. This study aims to delineate the role of neprilysin, a metalloprotease known for its role in modulating vasoactive peptides, in the pathophysiology of PE. Methods: We recruited a cohort of 57 participants, comprising 38 patients diagnosed with PE and 19 healthy controls, matched for demographic and clinical characteristics. Neprilysin expression was assessed in serum and placental tissues through quantitative RT-qPCR and Western blot analyses. Functional impacts of neprilysin modulation were explored via siRNA knockdown and overexpression in HTR8/SVneo cells, followed by assessments of oxidative stress, mitochondrial function, apoptosis, and trophoblast invasion using various biochemical assays including CCK-8, DCFH-DA, JC-1 staining, and flow cytometry. Results: Our results demonstrate a marked overexpression of neprilysin in the serum and placental tissues of PE patients compared to healthy controls. Elevated neprilysin levels were positively correlated with increased systolic and diastolic blood pressures. In functional assays, neprilysin knockdown alleviated H Conclusion: These findings establish neprilysin as a critical mediator in the pathogenesis of PE, where its aberrant overexpression is linked to exacerbated hypertensive symptoms and impaired trophoblast function. The interaction between neprilysin and IGF2BP1 provides a potential therapeutic target for mitigating the progression of PE, suggesting avenues for future intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.